Merck - PDFSEARCH.IO - Document Search Engine

Merck
Results: 2277

#	Item
281	MS&D logo_no qualifier_2 lines Add to Reading List Source URL: www.merck.com Language: English - Date: 2015-03-26 19:23:33 Merck Dosage forms Schering-Plough Ezetimibe Lactams Statin Niacin Tablet Prescription medication Chemistry Medicine Pharmacology
282	Public Policy Statement: Direct-toConsumer Broadcast Advertising in the United States Merck believes that Direct-to-Consumer (DTC) advertising can be an important and helpful way to inform patients about diseases that ma Add to Reading List Source URL: www.merck.com Language: English - Date: 2015-03-26 19:21:51 Pharmaceutical sciences Pharmacology Clinical research Merck Manual of Diagnosis and Therapy Food and Drug Administration Pharmaceutical Research and Manufacturers of America Pharmaceutical marketing Advertising Direct-to-consumer advertising Merck
283	Public Policy Statement: Charitable Product Donations • Merck is committed to enabling access to our medicines and vaccines to populations worldwide. In working towards this goal, the Company engages in a wide range of Add to Reading List Source URL: www.merck.com Language: English - Date: 2015-03-26 19:21:51 Donation Medicine Merck Ivermectin Merck Manual of Diagnosis and Therapy
284	Public Policy Statement: Medicare Medicare, created in 1965, is a program that provides health care for U.S. seniors (people 65 years of age and older) and people under age 65 with certain disabilities. The program cove Add to Reading List Source URL: www.merck.com Language: English - Date: 2015-03-26 19:21:51 Federal assistance in the United States Healthcare reform in the United States Presidency of Lyndon B. Johnson Managed care Medicare Advantage Medicare Out-of-pocket expenses United States National Health Care Act Nursing home Health Medicine Pharmaceuticals policy
285	Interim Results from SAILING Study, One of the Phase III Studies of the Integrase Inhibitor “Dolutegravir”, Disclosed by ViiV Healthcare Osaka, Japan, March 7, Shionogi & Co., Ltd. (Head Office: Osaka; Preside Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Organic chemistry Medicine Amides Merck Oxadiazoles Raltegravir Integrase Dolutegravir ViiV Healthcare Integrase inhibitors Chemistry Organofluorides
286	Public Policy Statement: Independent Expenditure Statement Merck has not used corporate funds to make any direct independent expenditures on behalf of candidates running for public office and does not currently have plan Add to Reading List Source URL: www.merck.com Language: English - Date: 2015-03-26 19:21:51 Federal Election Commission Lobbying in the United States Politics Jack Minnis Merck Independent expenditure Merck Manual of Diagnosis and Therapy
287	Public Policy Statement: The Uninsured / Health Care Reform in the U.S. Merck supports health care system reform in the U.S. that will ensure affordable access to health care coverage for all Americans. There are approxi Add to Reading List Source URL: www.merck.com Language: English - Date: 2015-03-26 19:21:51 Health insurance Health care reform Medicaid Health care reform in the United States Health insurance in the United States Healthcare reform in the United States Health Medicine
288	MSD Malaysia’s Notice of Data Practices for Employment-Related Purposes FACTS Privacy at Merck Add to Reading List Source URL: www.msd-malaysia.com Language: English - Date: 2015-03-20 03:50:36 Merck & Co. Readington New Jersey Schering-Plough Internet privacy MSD Surveillance Ethics Privacy Dow Jones Industrial Average
289	Microsoft Word - Ecuador - January 2008 clean.doc Add to Reading List Source URL: wp.aaccla.org Language: English - Date: 2015-04-21 17:07:32 Readington New Jersey Schering-Plough Ecuador Citigroup Economy of the United States Ivermectin Pharmacology Medicine Merck Dow Jones Industrial Average Merck & Co.
290	News Release June 8, 2011 Affectis Pharmaceuticals and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases Merck Serono to develop compounds from Affectis targeting P2X7 receptors Add to Reading List Source URL: www.bayernkapital.de Language: English - Date: 2011-06-14 06:59:15 Merck KGaA Pharmacology Serono Merck & Co. Serostim Kommanditgesellschaft auf Aktien Interferon beta-1a Merck Manual of Diagnosis and Therapy Genset Corporation Merck Pharmaceutical industry Pharmaceutical sciences

UPDATE